Adcytherix
Marseille
About Adcytherix
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC) to treat diseases with a high unmet need, including cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $155.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2025)
- Website: adcytherix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Oncology, Product Design
Social Profiles
Canonical: https://fsome.com/organization/adcytherix-60394 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.